Financial operations in UK telehealth is structurally different from general ecommerce. Refund decisions intersect with clinical decisions. Chargeback defence requires medical records. Subscription billing for prescribed medications has VAT and HMRC nuances most operators do not anticipate. The HRT-PPC changed the economic landscape in 2023. This piece is the financial-ops view for clinic and brand operators — the parts you do not see in the marketing pitch.

The UK telehealth payment stack — Stripe, PayPal, BNPL

Most UK telehealth brands run a payment stack of Stripe (cards, subscriptions, Klarna), PayPal (PayPal Pay-in-3), Apple Pay, and Google Pay. Each provider has different fee structures, settlement timing, and dispute handling. Stripe dominates because the developer ergonomics and subscription primitives are strongest. The financial-ops decision is rarely about provider — it is about how the operator handles edge cases (failed renewals, partial refunds, chargebacks) within whatever provider they pick. Multi-provider redundancy is increasingly common at scale.

Subscription vs one-off purchase economics

Subscription billing reduces churn and increases LTV but introduces failed-renewal handling, regulatory complications around prescription validity at renewal time, and patient-expectation management. One-off billing is operationally simpler but extracts less LTV per patient. The right answer is category-dependent: HRT and weight management lean subscription with built-in clinical-review cadence. First-time ED or hair loss often lean one-off until the patient is established. The decision shapes everything downstream.

Refund policy and how it interacts with clinical decisions

Refund policy in UK telehealth is uniquely complex because clinical and commercial decisions overlap. The medication was dispensed in good faith against a valid prescription. The patient regret factor is real, but the regulatory frame is strict. Best practice: refund pre-dispense cancellations in full, refund post-dispense returns at the platform's discretion under MHRA guidance, and never refund based on patient outcome alone. Document every decision. The refund ledger becomes audit material if a regulator asks why a category has unusual return patterns.

Chargebacks — the categories most affected and how to defend

Chargeback rates in UK telehealth concentrate in three categories: men's sexual health (impulse purchase combined with privacy concerns), weight management (outcome-dispute pattern), and ADHD assessment (concerns around private versus NHS pathway). Defending chargebacks requires comprehensive documentation: prescription record, consultation transcript or questionnaire response, dispatch confirmation, and patient communication history. Brands that invest in chargeback documentation upfront defend successfully; brands that do not accept losses they could have prevented.

HMRC and VAT on UK medication sales

VAT treatment of UK medication sales is category-dependent. Prescription medicines are generally zero-rated for VAT when dispensed against a valid UK prescription. The supply of medical services by registered professionals can be VAT-exempt under specific conditions. The interaction between supplying medical advice and supplying medication needs careful structuring — get it wrong and HMRC restitution can be significant. Professional advice from a tax specialist familiar with healthcare supply structures is non-optional. PExpo handles the medication-supply side of the VAT structure for both clinic and white-label customers.

HRT-PPC interaction and the 2023 economics shift

The NHS HRT-PPC, introduced in April 2023, provides annual prescription cover for HRT at a current rate around £19.30 per year. This materially shifted private HRT economics. Brands operating in HRT need to model two patient populations: those for whom price is the binding constraint (best served by NHS route) and those for whom access, choice, and continuity are the constraint (well-served by private). The financial model should reflect this duality — pretending the NHS route does not exist is a credibility problem with sophisticated patients.

Key takeaway

Refund policy in UK telehealth must respect that medication was dispensed in good faith against a valid prescription. Refund decisions are clinical-commercial hybrids — not pure customer-service calls. Document every one.

Chargeback defence is won at signing, not at dispute time. Document the patient journey end-to-end or accept the losses.

Financial operations in UK telehealth is denser than general ecommerce and easier than most operators expect, provided they invest upfront in policy clarity, documentation discipline, and provider relationships. The brands that get it right treat financial ops as a first-class function alongside clinical and operational. The brands that get it wrong lose money on chargebacks they could have defended and on VAT errors they could have avoided. For the platform-side commercial structure underneath these flows, our pricing page shows how PExpo handles the medication-supply economics, and our brand model page shows the broader operational scope.